Medical Media Holdings (MMH) is dedicated to disseminating new, evidence-based information on the diagnosis and treatment of cancer and general medicine topics. MMH comprises CancerNet, which is devoted to cancer-related issues, and MedNet, which concentrates on general medicine topics. MMH develops comprehensive curricula with a series of continuing medical education (CME) and continuing education (CE) activities to educate medical oncologists, radiation oncologists, surgical oncologists, pulmonologists, primary care physicians, diabetologists, translational investigators, nurses, nurse practitioners, physician assistants and pharmacists on the latest advances in the diagnosis and treatment of malignancies such as lung cancer, head & neck cancer, breast cancer, colorectal cancer, non-colorectal gastrointestinal cancers, genitourinary cancers, hematological malignancies, diabetes, asthma, dermatology, ophthalmology, epilepsy, multiple sclerosis, Parkinson’s disease, migraine, interstitial lung disease, and dyslipidemia. MMH designs educational activities based on the identified knowledge, skills/strategy, and performance gaps. Our programs promote the exchange of nuances in the diagnosis and treatment options between community-based physicians, healthcare providers, academic physicians, and clinical/translational researchers. Our CME/CE programs are offered in several formats such as virtual live programs, regional symposia, and web-based enduring online CME/CE activities. These programs will include interactive and didactic presentations from known thought leaders from academic and clinical settings, with ample opportunity for participant interaction with faculty to improve knowledge acquisition and retention. The web-based online CME activities are offered as roundtable panel discussions and enduring webcast formats designed to reach a large target audience. The enduring online CME activities have a 1-year validity and offer a greater shelf life for the content.